Congress trades
CDK Global, Inc. (CDK)
About CDK Global, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Technology
- Industry
- Software - Application
- Chief executive
- Brian Krzanich
- Employees
- 6,500
- Listed since
- Jun 5, 2014
- Market value
- -
- Price to earnings
- 6.5
- Earnings per share
- $8.44
- Dividend yield
- -
Earnings
6 reported quarters · next on Aug 16, 2022| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q3 FY2022reported May 5, 2022 | $0.78 | $0.75 | $459.7M | $441.3M | EPS beatRevenue beat |
| Q2 FY2022reported Feb 3, 2022 | $0.74 | $0.65 | $436.7M | $467.5M | EPS beatRevenue miss |
| Q1 FY2022reported Nov 2, 2021 | $0.77 | $0.67 | $440.0M | $441.1M | EPS beatRevenue in line |
| Q4 FY2021reported Aug 17, 2021 | $0.66 | $0.67 | $420.1M | $441.1M | EPS in lineRevenue miss |
| Q3 FY2021reported May 6, 2021 | $0.69 | $0.69 | $433.1M | $428.9M | EPS in lineRevenue in line |
| Q2 FY2021reported Feb 8, 2021 | $0.59 | $0.65 | $406.3M | $503.8M | EPS missRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in CDK
20 disclosures of 23 on record · median 39d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | +0.7%S&P -7.1% · vs S&P 500 +7.8% | May 6, 2022 | Jun 14, 2022 | 39d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | +0.6%S&P -7.7% · vs S&P 500 +8.4% | May 5, 2022 | Jun 14, 2022 | 40d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | +14.6%S&P -14.4% · vs S&P 500 +29.0% | Mar 21, 2022 | Apr 18, 2022 | 28d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | +15.1%S&P -10.2% · vs S&P 500 +25.4% | Mar 10, 2022 | Apr 18, 2022 | 39d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | +24.9%S&P -14.4% · vs S&P 500 +39.3% | Feb 15, 2022 | Mar 17, 2022 | 30d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | +29.6%S&P -13.6% · vs S&P 500 +43.2% | Jan 28, 2022 | Feb 23, 2022 | 26d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | +35.8%S&P -17.6% · vs S&P 500 +53.4% | Dec 14, 2021 | Jan 27, 2022 | 44d |
| Robert C. \'Bobby\' ScottFiled late | Stock | Sale | $1,001 - $15,000 | +6.3%S&P +2.7% · vs S&P 500 +3.6% | Dec 30, 2020 | Sep 8, 2021 | 252d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +10.2%S&P -10.8% · vs S&P 500 +21.0% | Jun 30, 2021 | Aug 3, 2021 | 34d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | +4.1%S&P -7.8% · vs S&P 500 +11.9% | May 11, 2021 | Jun 14, 2021 | 34d |
| Michael T. McCaul | Stock | Purchase | $50,001 - $100,000 | +5.3%S&P +2.7% · vs S&P 500 +2.7% | Dec 17, 2020 | Jan 25, 2021 | 39d |
| Susie LeeJointFiled late | Stock | Sale | $1,001 - $15,000 | +82.4%S&P +54.0% · vs S&P 500 +28.4% | Apr 3, 2020 | Jun 15, 2020 | 73d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +54.7%S&P +39.4% · vs S&P 500 +15.4% | Apr 8, 2020 | Apr 27, 2020 | 19d |
| Susie LeeJointFiled late | Stock | Purchase | $1,001 - $15,000 | +25.7%S&P +34.7% · vs S&P 500 -9.1% | Aug 14, 2019 | Sep 30, 2019 | 47d |
| Susie LeeJoint | Stock | Purchase | $1,001 - $15,000 | +24.6%S&P +30.7% · vs S&P 500 -6.0% | Aug 29, 2019 | Sep 30, 2019 | 32d |
| Susie LeeJoint | Stock | Purchase | $1,001 - $15,000 | +7.8%S&P +28.4% · vs S&P 500 -20.6% | Jul 17, 2019 | Aug 29, 2019 | 43d |
| Susie LeeJoint | Stock | Purchase | $1,001 - $15,000 | +7.3%S&P +27.9% · vs S&P 500 -20.6% | Jul 18, 2019 | Aug 29, 2019 | 42d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | -1.1%S&P +41.2% · vs S&P 500 -42.3% | Feb 8, 2019 | Feb 25, 2019 | 17d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | -5.1%S&P +38.2% · vs S&P 500 -43.3% | Oct 18, 2018 | Nov 28, 2018 | 41d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | -16.1%S&P +40.5% · vs S&P 500 -56.6% | Jul 2, 2018 | Jul 25, 2018 | 23d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 6, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded CDK?
Michael T. McCaul, Robert C. \'Bobby\' Scott, Lois Frankel, Susie Lee disclosed CDK transactions in the filings shown here.
How quickly are CDK trades disclosed?
Congressional disclosures took a median of 39 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.